That perspective is especially understandable considering that more than half of US adults could be eligible for GLP-1 use either for diabetes, obesity, or heart conditions - the overall population who may want/need access to these drugs is large enough to be cause for concern for any payer - even those as large and well-funded as the US government
How Semaglutide Works After eating, your intestines release GLP-1, which: Stimulates insulin release, lowering blood sugar
Common positive reports include reduced joint stiffness and morning pain (likely primarily from weight loss), improved energy levels after initial adjustment, better mood and reduced brain fog, improved sleep quality, and feeling that their autoimmune medications "work better" than before starting tirzepatide
Taking away semaglutide as well, however, will truly cut people off from medicine that has transformed their lives
Simply adding another substance (e.g
It can also help support thyroid hormones, heart health, liver function, and kidney support